無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ラテンアメリカの自動微生物検査市場:サプライヤー各社の市場シェア・戦略、分野別の市場規模・売上高の予測

2018 Latin America Automated Microbiology Market: A 7-Country Analysis

発行 Venture Planning Group 商品コード 509952
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.61円で換算しております。

Local License: 同一事業所内

Back to Top
ラテンアメリカの自動微生物検査市場:サプライヤー各社の市場シェア・戦略、分野別の市場規模・売上高の予測 2018 Latin America Automated Microbiology Market: A 7-Country Analysis
出版日: ページ情報: 英文
概要

当レポートでは、ラテンアメリカ諸国における自動微生物検査の技術・市場動向について分析し、現在/将来の検査技術の概略や水準、主要製品の市場動向見通し (今後5年間分、金額・数量ベース)、各国市場の詳細動向、主要企業のプロファイル、今後の市場成長の可能性、新たな事業拡張戦略などについて調査しております。

第1章 イントロダクション

第2章 自動微生物検査市場のビジネス環境

第3章 新製品の開発機会

第4章 分散型検査製品の設計基準

第5章 代替的な市場普及戦略

第6章 潜在的な市場参入障壁とリスク

第7章 市場・技術の概要

  • イントロダクション
  • 主な試料の種類
  • 検査の用途
  • 主な微生物検査用自動/半自動装置
  • 新規の診断技術

第8章 国別分析:各種製品の販売額・販売量、サプライヤー別市場シェア (全100種類:分子診断、微生物同定、抗生物質感受性、血液培養、尿スクリーニング、免疫診断検査)

  • アルゼンチン
  • ブラジル
  • チリ
  • コロンビア
  • メキシコ
  • ペルー
  • ベネズエラ

第9章 競合企業分析

  • Abbott
  • Affymetrix/Thermo Fisher
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • CellMark Forensics/LabCorp
  • Cepheid
  • Decode
  • Diadexus
  • Diamedix
  • DiaSorin
  • 栄研化学
  • Elitech Group
  • Enzo Biochem
  • Exact Sciences
  • 富士レビオ
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Illumina
  • Kreatech/Leica
  • Li-Cor Biosciences
  • Lonza
  • Monogram Biosciences
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • 島津製作所
  • Siemens
  • Sierra Molecular
  • タカラバイオ
  • Tecan
  • Wallac/PE
  • 和光純薬工業

図表一覧

目次
Product Code: VPAM28679

This new 7-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test.

The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the automated microbiology market during the next five years. The report examines key trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for 100 molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive 7-country survey will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Country Analyses

Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela

Specimen Types

- Urine Sterile Fluids: Blood, Serum, CSF Throat Swabs, Respiratory Secretions Genital Secretions Stool Abscess/Wound Sputum Saliva

Applications

- Microbial Identification  Antibiotic Susceptibility  Urine Screening  Blood Cultures

Review of Major Automated Systems

- Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers marketed by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh and other suppliers.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.

- Companies developing or marketing microbiology products, by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Opportunities and Strategic Recommendations

- Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Contains over 550 pages and 96 tables

Table of Contents

I. Introduction

II. Automated Microbiology Market Business Environment

III. New Product Development Opportunities

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies

VI. Potential Market Entry Barriers and Risks

VII. Market and Technology Overview

  • A. Introduction
    • 1. Major Factors Affecting Market Penetration for Microbiology Instrumentation
    • 2. Traditional Practices
    • 3. Technological Challenges
    • 4. Automation: Impact on the Microbiology Laboratory and the Patient
  • B. Major Specimen Types
    • 1. Urine
    • 2. Sterile Fluids: Blood, Serum, and CSF
    • 3. Throat Swabs and Respiratory Secretions
    • 4. Genital Secretions
    • 5. Stool
    • 6. Abscess/Wound
    • 7. Sputum
    • 8. Saliva
  • C. Test Applications
    • 1. Microbial Identification
    • 2. Antibiotic Susceptibility
    • 3. Urine Screening
      • a. Photometry
      • b. Bioluminescence
      • c. Colorimetric Filtration
      • d. Enzymatic Detection
      • e. Optical Detection
    • 4. Blood Cultures
  • D. Major Automated and Semi-automated Microbiology Systems
    • 1. Multiple Purpose Microbiology Systems
    • 2. Specialized Microbiology Systems
    • 3. Molecular Diagnostic Systems
    • 4. Immunodiagnostic Systems
  • E. Emerging Diagnostic Technologies
    • 1. Molecular Diagnostics (Amplification Methods, Sequencing, Microarrays/Biochips)
      • a. DNA Sequencing
      • b. DNA and RNA Probe Technologies
      • c. Detection Technologies
      • d. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
    • 2. Monoclonal Antibodies
    • 3. Immunoassays
    • 4. Differential Light Scattering
    • 5. Information Technology
    • 6. Artificial Intelligence
    • 7. Liposomes
    • 8. Flow Cytometry
    • 9. Chromatography
    • 10. Diagnostic Imaging
    • 11. Gel Microdroplets
    • 12. Other

VIII. Country Analyses: Sales and Volume Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests, Supplier Shares

  • Argentina
  • Brazil
  • Chile
  • Colombia
  • Mexico
  • Peru
  • Venezuela

IX. Competitive Assessments

  • Abbott
  • Affymetrix/Thermo Fisher
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • CellMark Forensics/LabCorp
  • Cepheid
  • Decode
  • Diadexus
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Exact Sciences
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Illumina
  • Kreatech/Leica
  • Li-Cor Biosciences
  • Lonza
  • Monogram Biosciences
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan
  • Wallac/PE
  • Wako

List of Tables

  • Argentina
  • Microbiology Specimen Volume Forecast by Type
  • Argentina
  • Microbiology Test Volume Forecasts by Application
  • Argentina
  • Microbiology Consumables Market Forecast by Application
  • Argentina
  • Infectious Disease Test Volume Forecast by Assay
  • Argentina
  • Infectious Disease Diagnostics Market Forecast by Test
  • Argentina
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Argentina
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Brazil
  • Microbiology Specimen Volume Forecast by Type
  • Brazil
  • Microbiology Test Volume Forecasts by Application
  • Brazil
  • Microbiology Consumables Market Forecast by Application
  • Brazil
  • Infectious Disease Test Volume Forecast by Assay
  • Brazil
  • Infectious Disease Diagnostics Market Forecast by Test
  • Brazil
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Brazil
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Chile
  • Microbiology Specimen Volume Forecast by Type
  • Chile
  • Microbiology Test Volume Forecasts by Application
  • Chile
  • Microbiology Consumables Market Forecast by Application
  • Chile
  • Infectious Disease Test Volume Forecast by Assay
  • Chile
  • Infectious Disease Diagnostics Market Forecast by Test
  • Chile
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Chile
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Colombia
  • Microbiology Specimen Volume Forecast by Type
  • Colombia
  • Microbiology Test Volume Forecasts by Application
  • Colombia
  • Microbiology Consumables Market Forecast by Application
  • Colombia
  • Infectious Disease Test Volume Forecast by Assay
  • Colombia
  • Infectious Disease Diagnostics Market Forecast by Test
  • Colombia
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Colombia
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Mexico
  • Microbiology Specimen Volume Forecast by Type
  • Mexico
  • Microbiology Test Volume Forecasts by Application
  • Mexico
  • Microbiology Consumables Market Forecast by Application
  • Mexico
  • Infectious Disease Test Volume Forecast by Assay
  • Mexico
  • Infectious Disease Diagnostics Market Forecast by Test
  • Mexico
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Mexico
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Peru
  • Microbiology Specimen Volume Forecast by Type
  • Peru
  • Microbiology Test Volume Forecasts by Application
  • Peru
  • Microbiology Consumables Market Forecast by Application
  • Peru
  • Infectious Disease Test Volume Forecast by Assay
  • Peru
  • Infectious Disease Diagnostics Market Forecast by Test
  • Peru
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Peru
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Venezuela
  • Microbiology Specimen Volume Forecast by Type
  • Venezuela
  • Microbiology Test Volume Forecasts by Application
  • Venezuela
  • Microbiology Consumables Market Forecast by Application
  • Venezuela
  • Infectious Disease Test Volume Forecast by Assay
  • Venezuela
  • Infectious Disease Diagnostics Market Forecast by Test
  • Venezuela
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Venezuela
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Bartonella Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Clostridium Tests
  • Major Companies Developing or Marketing Coronavirus Tests
  • Major Companies Developing or Marketing Cryptosporidium Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Echovirus Tests
  • Major Companies Developing or Marketing Enterovirus Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Giardia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Hantavirus Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Lymphogranuloma Tests
  • Major Companies Developing or Marketing Malaria Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Microsporidium Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Papilloma Virus Tests
  • Major Companies Developing or Marketing Parvovirus Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Septicemia Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Staphylococci Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Toxoplasmosis Tests
  • Major Companies Developing or Marketing Trichomonas Tests
  • Major Companies Developing or Marketing Tuberculosis Tests
  • Major Companies Developing or Marketing West Nile Tests
  • Major Companies Developing or Marketing Yersinia Tests
Back to Top